Table 1.

Kidney and SPK transplant recipients admitted with acute rejection within 1 week of stay-at-home state orders during COVID-19 pandemic

Pt	Sex	Age (yr)	Race	Time since transplant (yr)	Transplant type	Induction	Cause of ESRD	Maintenance IS	Scr baseline (mg/dl)	Nonadherence	Presentation	Scr at presentation (mg/dl)	Biopsy	Treatment	Outcomes
1	M	43	W	5	LUKT	rATG	PCKD	T/M/P	1.6	Yes	Nausea, vomiting	30	ND	None	Dialysis
2	M	37	AA	7	LUKT	IL-2 (−)	HTN	T/M/P	1.3	Yes	Nausea, vomiting	16	TCMR	Pulse steroids	Dialysis
3	M	38	W	11	SPK	rATG	DM	T/M/P	1	Yes	Nausea, vomiting	1.5	ND	None	Failed pancreas
4	F	22	W	5	DD	rATG	MCKD	T/M/P	0.9	Yes	Elevated UPC	1	ABMR	Pulse steroids i.v. Ig
5	F	37	W	3	LUKT	rATG	HTN	T/M/P	1.5	Yes	Elevated creatinine	2.5	Mixed	Pulse steroids i.v. Ig
6	F	59	AA	5	DD	rATG	HTN	T/L/P	2	Yes	Elevated creatinine	3	ABMR	Increase baseline IS

AA, African American; ABMR, antibody-mediated rejection; COVID-19, coronavirus disease 2019; DD, deceased donor; DM, diabetes mellitus; ESRD, end-stage renal disease; F, female; HTN, hypertension; IL-2 (−), interleukin-2 blockade; IS, immunosuppression; LUKT, living unrelated kidney transplant; M, male; MCKD, medullary cystic kidney disease; ND, not done; PCKD, polycystic kidney disease; Pt, patient; rATG, rabbit antithymocyte globulin; Scr, serum creatinine; SPK, simultaneous pancreas-kidney transplantation; TCMR, T cell–mediated rejection; T/L/P, tacrolimus, leflunomide, prednisone; T/M/P, tacrolimus, mycophenolate, prednisone; UPC, urine protein-creatinine ratio; W, white.